PROVIDER PROFILE · NPI 1053532986

Laura Arce-GomezMD

PRACTICECENTRO DE SALUD DE LA COMUNIDAD DE SAN YSIDRO, INC.See all providers at this practice →

Family PracticeChula Vista, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$753

Peer benchmark

Total Medicare services vs. 8,228 Family Practice providers in CA — below median (cohort median 411).

PRESCRIBING · PART D · 2024

Total Rx claims

3,968

Beneficiaries

—

Total drug cost

$445K

Distinct drugs

Brand share

15.9%

Top prescribed drugs

Atorvastatin Calcium344 claims

Metformin Hcl269 claims

Levothyroxine Sodium242 claims

Gabapentin203 claims

Losartan Potassium196 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$348

Payment records

By payment type

Food and Beverage$348

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050077

Hospital

REFERRAL NETWORK

Where Laura Arce-Gomez's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
ASL-DEN LLC	125	302
Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ	57	113
Charles Love Dermatology · West Des Moines, IA	12	14
Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ	12	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history